VanEck Junior Gold Miners vs InMode Ltd — how do they compare? VanEck Junior Gold Miners trades at $114.32 (market cap $8.22B), while InMode Ltd trades at $14.22 (market cap $809.93M). The key difference: VanEck Junior Gold Miners is far larger — about 10.1× InMode Ltd's market cap, and InMode Ltd is more actively traded (365,490 versus 3,212,198). Which is the better fit depends on your goals — on Pluang, investors hold VanEck Junior Gold Miners for 41 Days and InMode Ltd for 28 Days on average.
| GDXJ | INMD | |
|---|---|---|
Market Cap | $8.22B | $809.93M |
Volume | 3,212,198 | 365,490 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $156.19 | $16.62 |
52-Week Low | $87.56 | $12.76 |
Typical Hold Time | 41 Days | 28 Days |
Enterprise Value | — | $313.27M |
Signals from Pluang's Aura AI — not financial advice
GDXJ, the VanEck Junior Gold Miners ETF, trades at $114.39, up 4.81% in the last 24 hours. The technical outlook is bearish, with moving averages and key indicators like ADX signaling selling pressure. Recent news highlights multiple junior gold mining companies being added to the ETF's underlying index, potentially increasing its diversification and appeal. However, key financial ratios such as P/E and P/S are unavailable for direct analysis of the ETF's valuation.
The outlook for GDXJ is mixed, balancing recent index additions against a bearish technical backdrop. Investment opportunities lie in exposure to junior gold miners amid high gold prices, but risks include sector volatility and the ETF's current negative momentum. Investors should weigh the potential for broader market recognition against prevailing selling pressure.
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →